Tag: Department of Pharmaceuticals
Govt invites eligible Medical Devices Firms Category B of PLI scheme
The Department of Pharmaceuticals (DoP) has called for applications from eligible medical device firms for the newly created Category B of the...
Govt invites applications to produce Vitamin B1
The Department of Pharmaceuticals (DoP) has extended an invitation to eligible active pharmaceutical ingredient (API) manufacturers in the country to apply for...
Govt to roll out schemes for strengthening Pharma Industry
The Department of Pharmaceuticals (DoP) is planning to roll out a series of initiatives under the banner of Schemes for "Strengthening Pharmaceuticals...
Pharma Industry urges Govt to reduce prices of IP 2022
The SME Pharma Industries-Confederation (SPIC), a body of thousands of small-scale pharma units in the country, has appealed to the department of...
DoP revises list of Medical Devices for which no local manufacturers...
The Department of Pharmaceuticals (DoP) has revised the list of medical devices for which the government and public sector procurers could not...
Govt extends timeline to apply for PLI scheme
The Department of Pharmaceuticals (DoP) has extended the deadline for submission of application for the production linked incentive (PLI) scheme for pharmaceuticals...
Govt to come up with FAQs on PLI scheme soon
The Department of Pharmaceuticals (DoP) is in the process of compiling and publishing a list of Frequently Asked Questions (FAQs) based on...
PLI Scheme: Approvals accorded for Promotion of APIs
The Department of Pharmaceuticals, with an objective to attain self-reliance and reduce import dependence in critical Bulk Drugs - Key Starting Materials...
Govt issues revised guidelines under PLI scheme for Medical Devices
The Department of Pharmaceuticals (DoP) has issued revised guidelines under the production linked incentive (PLI) scheme for promoting domestic manufacturing of medical...
High Court: Ensure immediate supply of Tocilizumab
In view of the "acute shortage" of Tocilizumab which is prescribed to a large number of C-19 patients, the Delhi High Court has directed the Union Health...
India bans export of Remdesivir drug
As C-19 cases surge in the country , the government of India on Sunday ordered prohibition on the export of Remdesivir drug...
19 Medical Devices added to public procurement policy: DoP
The Department of Pharmaceuticals (DoP) has incorporated 19 medical devices in the revised guidelines of the public procurement policy. The revised order...
Drug Price Control: A Double Edged Sword: Article
In May 2013, the Department of Pharmaceuticals (DoP) of India brought 348 medicines— essential and lifesaving drugs from the National List of Essential Medicines (NLEM)—under price control by...
NPPA: 8,200 Cr outstanding amount related to 880 overcharging cases pending
Total outstanding amount of Rs. 8,200 crore related to 880 overcharging cases of Drug Prices Control Order (DPCO) violations are pending with...
Medical x-ray machines: DoP to promote domestic manufacturing
The Department of Pharmaceuticals (DoP) has prepared a phased manufacturing programme (PMP) in consultation with department of revenue (DoR) to promote domestic...
Govt issues environmental clearance for Bulk Drugs
The Union environment ministry has finally issued environmental clearance for active pharmaceutical ingredients (APIs) and intermediates as single category instead of individual...
Pharma industry a ‘Strategic Sector’: Parliamentary panel
New Delhi: Highlighting the need for strong indigenous pharma companies, a Parliamentary panel has recommended that the pharma industry should be categorised as a "strategic sector"...
DoP proposal: One time settlement for overcharging disputes
The Department of Pharmaceuticals (DoP) has proposed draft framework of Special One-Time Settlement (SOTS) scheme to pharma companies for fast track recovery...
PLI Scheme for Intermediates and APIs approved
PLI Scheme for Intermediates and APIs approved
The Applications of following companies, which have committed more than the minimum...
Pharma marketing: Govt soon to share draft Uniform Code
Even as the Department of Pharmaceuticals (DoP) has been seeking compliance reports from industry regarding implementation of the Uniform Code of Pharmaceutical...
DoP issues revised guidelines for procurement of drugs
Revised guidelines for procurement of drugs
The Department of Pharmaceuticals (DoP) recently issued revised guidelines of Public Procurement Order...
Medical devices industry seeks clarity on PLI scheme
The medical devices industry has sought clarity on the Central government’s claim that medical device sector has been adequately covered under the...
DoP: Revised guidelines for procurement of medical devices
The Department of Pharmaceuticals (DoP) has issued revised guidelines for implementing the provisions of public procurement (preference to Make in India) Order...
DoP issues letter to Pharma Associations to ensure adherence to UCPMP
The Department of Pharmaceutical (DoP) has issued a letter to the pharma industry’s key associations, namely; IDMA, BDMA, IPA, OPPI and FOPE...